Sun Pharma Q3 Net Profit Rises 16% to ₹3,369 Crore on Broad-Based Growth by Economy India February 1, 2026 Sun Pharma Q3 Net Profit Rises 16% to ₹3,369 Crore on Broad-Based Growth
Himachal Pradesh Budget FY27: A Deep State Economy Analysis of Fiscal Pressures, Limited Capex, and Growth Challenges
WTO Reform at a Crossroads: India’s Pushback Against ‘Weaponised Transparency’ and the Future of Global Trade Governance